The M-Tiba app is revolutionising healthcare in Kenya
Mobile-based health wallet M-Tiba initially went nationwide in 2016, but has been increasingly influencing the healthcare industry across Kenya ever since.
Based on Safaricom’s M-Pesa platform, the app has been granted a wider audience as a result of its increased focus on connectivity and digitisation.
Developed by Safaricom, CarePay and PharmAccess Group, the app supports individuals to manage their healthcare expenses by enabling users to send, receive and save funds so that they may access patient care at reduced cost, supporting individuals and families alike.
With over 300 healthcare facilities partnered with the app, the mobile wallet has now gained up to a million users, revolutionising healthcare across Kenya.
M-Tiba has also partnered with The National Hospital Insurance Fund (NHIF) to provide healthcare insurance to 2,000 households, Capital Business reported last year.
“For many Kenyans, a trip to the clinic can create real financial strain. And it can have a knock-on effect in people holding down jobs, or having to sell their belongings to pay for basic care. This is a burden on low-income homes, with mothers and young children being particularly vulnerable,” explained Safaricom Chief Executive Officer Bob Collymore.
- Apollo Hospitals will support healthcare startups with signed MoU with IBM
- Effects of barcodes within healthcare supply chain management
- Conrad N. Hilton Foundation grants $300,000 to Lifenet International
The app has seen thousands of users sign up each day, where even employers are looking to utilise the platform.
“We needed a solution that was sustainable and manageable which could bring new insights into how to further improve staff health and wellbeing. We see M-TIBA as the future for the management of outpatient schemes by employers and insurers,” commented Kirimi Mpungu, Director of Administration at Oserian.
By empowering Kenyans to take control of their own healthcare, M-Tiba was awarded the 2017 Financial Times/IFC Transformational Business Award in Sustainable Development due to its emphasis on supporting the implementation of healthcare management across the country.
“We’ve built a platform that allows for a more efficient and transparent way of connecting patients, doctors, payers and governments,” Kees Van Lede, CEO of CarePay said.
“This award is a great recognition of how mobile – through innovative solutions like M-TIBA – is transforming access to essential services for millions of Kenyans,” Collymore added.
By enabling individuals to increasingly access healthcare remains vital, so that they may access vital treatment where needed. This digital tool is a step in the right direction, where Kenya is embracing new mobile solutions, transforming traditional models of healthcare.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”